{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:06:30Z","timestamp":1763755590931,"version":"3.45.0"},"reference-count":20,"publisher":"Oncology Nursing Society (ONS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Journal of Oncology Nursing"],"published-print":{"date-parts":[[2002,9,1]]},"DOI":"10.1188\/02.cjon.283-286","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T10:43:20Z","timestamp":1187865800000},"page":"283-286","source":"Crossref","is-referenced-by-count":3,"title":["Waldenstr\u00f6m's Macroglobulinemia"],"prefix":"10.1188","volume":"6","author":[{"given":"Jennifer A.","family":"McKenna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2007,2,13]]},"reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Alexanian, R., Weber, D., & Liu, F. (1999). Differential diagnosis of monoclonal gammopathies. <i>Archives of Pathology and Laboratory Medicine<\/i>, <i>123<\/i>, 108-113.","DOI":"10.5858\/1999-123-0108-DDOMG"},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Anagnostopoulos, A., Dimopoulos, M.A., Aleman, A., Weber, D., Alexanian, R., Champlin, R., et al. (2001). High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstr\u00f6m's macroglobulinemia. <i>Bone Marrow Transplantation<\/i>, <i>27<\/i>, 1027-1029.","DOI":"10.1038\/sj.bmt.1703041"},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Byrd, J.C., White, C.A., Link, B., Lucas, M.S., Velasquez, W.S., Rosenberg, J., et al. (1999). Rituximab therapy in Waldenstr\u00f6m's macroglobulinemia: Preliminary evidence of clinical activity. <i>Annals of Oncology<\/i>, <i>10<\/i>, 1525-1527.","DOI":"10.1023\/A:1008350208019"},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Dhodapkar, M.V., Jacobson, J.L., Gertz, M.A., Rivkin, S.E., Roodman, G.D., Tuscano, J.M., et al. (2001). Prognostic factors and response to fludarabine therapy in patients with Waldenstr\u00f6m's macroglobulinemia: Results of United States intergroup trial (Southwest Oncology Group S9003). <i>Blood<\/i>, <i>98<\/i>, 41-48.","DOI":"10.1182\/blood.V98.1.41"},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Dimopoulos, M.A., Galani, E., & Matsouka, C. (1999). Waldenstr\u00f6m's macroglobulinemia. <i>Hematology\/Oncology Clinics of North America<\/i>, <i>13<\/i>, 1351-1366.","DOI":"10.1016\/S0889-8588(05)70130-1"},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Dimopoulos, M.A., Panayiotidis, P., Moulopoulos, L.A., Sfikakis, P., & Dalakas, M. (2000). Waldenstr\u00f6m's macroglobulinemia: Clinical features, complications, and management. <i>Journal of Clinical Oncology<\/i>, <i>18<\/i>, 214-226.","DOI":"10.1200\/JCO.2000.18.1.214"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Dimopoulos, M.A., Zervas, C., Zomas, A., Kiamouris, C., Viniou, N.A., Grigoraki, V., et al. (2002). Treatment of Waldenstrom's macroglobulinemia with rituximab. <i>Journal of Clinical Oncology<\/i>, <i>20<\/i>, 2327-2333.","DOI":"10.1200\/JCO.2002.09.039"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Dimopoulos, M.A., Zomas, A., Viniou, N.A., Grigoraki, V., Galani, E., Matsouka, C., et al. (2001). Treatment of Waldenstr\u00f6m's macroglobulinemia with thalidomide. <i>Journal of Clinical Oncology<\/i>, <i>19<\/i>, 3596-3601.","DOI":"10.1200\/JCO.2001.19.16.3596"},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Fadil, A., & Taylor, D.E. (1998). The lung and Waldenstr\u00f6m's macroglobulinemia. <i>Southern Medical Journal<\/i>, <i>91<\/i>, 681-685.","DOI":"10.1097\/00007611-199807000-00017"},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Gertz, M.A., Fonseca, R., & Rajkumar, S.V. (2000). Waldenstr\u00f6m's macroglobulinemia. <i>Oncologist<\/i>, <i>5<\/i>, 63-67.","DOI":"10.1634\/theoncologist.5-1-63"},{"key":"E00011","doi-asserted-by":"crossref","unstructured":"Leblond, V., Levy, V., Maloisel, F., Cazin, B., Fermand, J.P., Harousseau, J.L., et al. (2001). Multicenter, randomized comparative trial of fludarabine and the combination of cyclophos-phamide-doxorubicin-prednisone in 92 patients with Waldenstr\u00f6m's macroglobulinemia in first relapse or with primary refractory disease. <i>Blood<\/i>, <i>98<\/i>, 2640-2644.","DOI":"10.1182\/blood.V98.9.2640"},{"key":"E00012","unstructured":"McDermott, M.K., & Bell, E.M. (1999). A review of Waldenstr\u00f6m's macroglobulinemia. <i>Clinical Journal of Oncology Nursing<\/i>, <i>3<\/i>, 107-111."},{"key":"E00013","unstructured":"Owen, R.G., Barrans, S.L., Richards, S.J., O'Connor, S.J., Child, J.A., Parapia, L.A., et al. (2001). Waldenstr\u00f6m's macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors. <i>American Journal of Clinical Pathology<\/i>, <i>116<\/i>, 420-428."},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"Owen, R.G., Johnson, S.A., & Morgan, G.J. (2000). Waldenstr\u00f6m's macroglobulinemia: Laboratory diagnosis and treatment. <i>Hematological Oncology<\/i>, <i>18<\/i>, 41-49.","DOI":"10.1002\/1099-1069(200006)18:2<41::AID-HON654>3.0.CO;2-W"},{"key":"E00015","unstructured":"Sommers, C. (1998). Immunity and inflammation. In C.M. Porth (Ed.), <i>Pathophysiology: Concepts of altered health states<\/i> (pp. 189-212). Philadelphia: Lippincott Williams and Wilkins."},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"Syms, M.J., Arcila, M.E., & Holtel, M.R. (2001). Waldenstr\u00f6m's macroglobulinemia and sensorineural hearing loss. <i>American Journal of Otolaryngology<\/i>, <i>22<\/i>, 349-353.","DOI":"10.1053\/ajot.2001.26494"},{"key":"E00017","doi-asserted-by":"crossref","unstructured":"Thalhammer-Scherrer, R., Geissler, K., Schwarzinger, I., Chott, A., Gisslinger, H., Knobl, P., et al. (2000). Fludarabine therapy in Waldenstr\u00f6m's macroglobulinemia. <i>Annals of Hematology<\/i>, <i>79<\/i>, 556-559.","DOI":"10.1007\/s002770000185"},{"key":"E00018","unstructured":"Treon, S.P., & Anderson, K.C. (2000). The use of rituximab in the treatment of malignant and nonmalignant plasma cell disorders. <i>Seminars in Oncology<\/i>, <i>27<\/i>(6 Suppl. 12), 79-85."},{"key":"E00019","doi-asserted-by":"crossref","unstructured":"West, N.Y., Fitzpatrick, J.E., David-Bajar, K.M., & Bennion, S.D. (1998). Waldenstr\u00f6m macroglobulinemia-induced bullous dermatosis. <i>Archives of Dermatology<\/i>, <i>134<\/i>, 1127-1131.","DOI":"10.1001\/archderm.134.9.1127"},{"key":"E00020","unstructured":"Wilkes, G.M., Ingwersen, K., & Barton-Burke, M. (Eds.). (2002). <i>Oncology nursing drug handbook.<\/i> Boston: Jones and Bartlett."}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/V648801M2R24R7V3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:54:04Z","timestamp":1763754844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/6\/5\/waldenstroms-macroglobulinemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,1]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,9,1]]}},"alternative-id":["V648801M2R24R7V3"],"URL":"https:\/\/doi.org\/10.1188\/02.cjon.283-286","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"type":"print","value":"1092-1095"},{"type":"electronic","value":"1538-067X"}],"subject":[],"published":{"date-parts":[[2002,9,1]]}}}